MARKET

PACB

PACB

Pacific Biosc
NASDAQ
1.360
-0.110
-7.48%
After Hours: 1.370 +0.01 +0.74% 19:45 04/24 EDT
OPEN
1.510
PREV CLOSE
1.470
HIGH
1.510
LOW
1.350
VOLUME
11.06M
TURNOVER
0
52 WEEK HIGH
14.55
52 WEEK LOW
1.250
MARKET CAP
364.41M
P/E (TTM)
-1.1245
1D
5D
1M
3M
1Y
5Y
PacBio moved to Neutral at JPMorgan after guidance cut
JPMorgan downgraded shares of PacBio to Neutral from Overweight. The gene sequencing company missed Q1 results and lowered its full-year outlook. Shares of Pac bio fell over 3% premarket on Monday. PacBio moved to Neutral at JPMorgan after guidance cut.
Seeking Alpha · 2d ago
Pacific Biosciences Cut to Neutral From Overweight by JP Morgan
Dow Jones · 2d ago
JP Morgan Downgrades Pacific Biosciences to Neutral
Benzinga · 2d ago
Weekly Report: what happened at PACB last week (0415-0419)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)
TipRanks · 2d ago
PACIFIC BIOSCIENCES OF CALIFORNIA INC <PACB.O>: JP MORGAN CUTS TO NEUTRAL FROM OVERWEIGHT
Reuters · 2d ago
Pacific Biosciences Is Maintained at Neutral by Goldman Sachs
Dow Jones · 5d ago
Pacific Biosciences Price Target Cut to $2.50/Share From $7.00 by Goldman Sachs
Dow Jones · 5d ago
More
About PACB
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

Webull offers Pacific Biosciences of California Inc stock information, including NASDAQ: PACB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PACB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PACB stock methods without spending real money on the virtual paper trading platform.